⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14936408 | 0.79 | NOS1 (0.65) | — | |
| SCHEMBL3506516 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL3372305 | 0.78 | NOS1 (0.52) | — | |
| SCHEMBL5378534 | 0.77 | — | — | |
| SCHEMBL607368 | 0.77 | — | — | |
| SCHEMBL1680220 | 0.75 | — | — | |
| SCHEMBL31340016 | 0.75 | — | — | |
| Praxadine SCHEMBL94070 | 0.75 | — | — | |
| SCHEMBL15101304 | 0.75 | — | — | |
| SCHEMBL14385207 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023016447-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2023-02-16 | — | — | WO | disclosed |
| EP-2919779-B1 | CANNABINOID RECEPTOR MEDIATING COMPOUNDS | US HEALTH (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10683270-B2 | Cannabinoid receptor mediating compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-06-16 | — | — | US | disclosed |
| EP-3495354-A1 | IDO1 INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF | Shandong Luye Pharmaceutical Co., Ltd. (CN) | 2019-06-12 | — | — | EP | disclosed |
| US-20180022706-A1 | CANNABINOID RECEPTOR MEDIATING COMPOUNDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-01-25 | — | — | US | disclosed |
| US-20170247321-A1 | TETRALIN AND INDANE DERIVATIVES AND USES THEREOF | ROCHE PALO ALTO LLC (US) | 2017-08-31 | — | — | US | disclosed |
| US-9670151-B2 | Tetralin and indane derivatives and uses thereof | ROCHE PALO ALTO LLC (US) | 2017-06-06 | — | — | US | disclosed |
| US-9309214-B2 | Method for manufacturing neuraminic acid derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-04-12 | — | — | US | disclosed |
| US-9303008-B2 | Method for manufacturing neuraminic acid derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-04-05 | — | — | US | disclosed |
| US-20150376156-A1 | NEURAMINIC ACID DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-31 | — | — | US | disclosed |
| US-20150376155-A1 | METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-31 | — | — | US | disclosed |
| US-20150266817-A1 | TETRALIN AND INDANE DERIVATIVES AND USES THEREOF | ROCHE PALO ALTO LLC (US) | 2015-09-24 | — | — | US | disclosed |
| US-20150259314-A1 | METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-09-17 | — | — | US | disclosed |
| US-20140018417-A1 | METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-01-16 | — | — | US | disclosed |
| US-8575370-B2 | Method for manufacturing neuraminic acid derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-11-05 | — | — | US | disclosed |
| US-20130197072-A1 | METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVES | DAIICHI SANKYO CO., LTD. (JP) | 2013-08-01 | — | — | US | disclosed |
| US-8455659-B2 | Method for manufacturing neuraminic acid derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-06-04 | — | — | US | disclosed |
| US-7981923-B2 | Tetralin and indane derivatives and uses thereof | ROCHE PALO ALTO LLC (US) | 2011-07-19 | — | — | US | disclosed |